- High gross margin of 98.8%
- Beat earnings estimates in 3 of the last 4 quarters
- +77.5% YTD performance
Lisata Therapeutics, Inc. stock upgraded to Buy Candidate
(Updated on Jun 23, 2026)
No changes to the price of Lisata Therapeutics, Inc. stock on the last trading day (Tuesday, 23rd Jun 2026). During the last trading day the stock fluctuated 2.49% from a day low at $3.42 to a day high of $3.51. The price has been going up and down for this period, and there has been a -0.29% loss for the last 2 weeks.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.70 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -30.63% during the next 3 months and, with a 90% probability hold a price between $1.16 and $2.57 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
LSTA Signals & Forecast
The Lisata Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.50. On a fall, the stock will find some support from the long-term average at approximately $3.34. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Monday, April 20, 2026, and so far it has risen 22.61%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Lisata Therapeutics, Inc. stock
Lisata Therapeutics, Inc. finds support from accumulated volume at $3.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0850 between high and low, or 2.49%. For the last week the stock has had daily average volatility of 2.11%.
Our recommended stop-loss: $3.33 (-4.02%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 44 days ago.)
Trading Expectations (LSTA) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Lisata Therapeutics, Inc. to open at $3.47, and during the day (based on 14 day Average True Range), to move between $3.40 and $3.54, which gives a possible trading interval of +/-$0.147 (+/-4.32%) up or down from last closing price. If Lisata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.32% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $3.48 (0.29%) than the support at $3.37 (2.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Lisata Therapeutics, Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
1.561
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $3.47 ( 0.144%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LSTA Performance
Trading levels for LSTA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.55 | 2.31% |
| R2 | 3.52 | 1.37% |
| R1 | 3.50 | 0.792% |
| Price | 3.47 | |
| S1 | 3.43 | -1.08% |
| S2 | 3.41 | -1.66% |
| S3 | 3.38 | -2.59% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.61 | 4.03% |
| R2 | 3.58 | 3.17% |
| R1 | 3.48 | 0.288% |
| Price | 3.47 | |
| S1 | 3.37 | -2.88% |
| S2 | 3.25 | -6.34% |
| S3 | 3.18 | -8.36% |
LSTA Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Oct 28, 2013 | Oct 28, 2013 | Oct 28, 2013 | $0.310 | 0.0321% |
| 2 | Apr 04, 2011 | Apr 04, 2011 | Apr 04, 2011 | $0.250 | 0.0096% |
FAQ
Click here for our free guide on how to buy Lisata Therapeutics, Inc. Stock.
Buy LSTA